The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits
Abstract
Background —Despite intense investigation, the effector of the infarct-limiting protection observed during the late phase of ischemic preconditioning (PC) remains unknown. The goal of this study was to test the hypothesis that late PC against myocardial infarction is mediated by the activity of nitric oxide synthase (NOS). Methods and Results —Conscious rabbits underwent a 30-minute coronary occlusion followed by 3 days of reperfusion. In group I (control group, n=10), infarct size (tetrazolium staining) averaged 56.8±5.3% of the risk region, which was decreased to 27.6±2.5% ( P <0.05) in rabbits preconditioned 24 hours earlier with a sequence of six 4-minute occlusion/4-minute reperfusion cycles (group II, n=10). When preconditioned rabbits were given the nonselective NOS inhibitor N ω -nitro- l -arginine (L-NA, 13 mg/kg IV [group III, n=8]) or the selective iNOS inhibitor aminoguanidine (AG, 150 mg/kg SC [group V, n=7]) before the 30-minute occlusion, the protective effect of late PC was completely abrogated; that is, infarct size (59.9±4.5% and 65.8±3.3%, respectively) was similar to that measured in the control group. Measurements of systolic wall thickening (sonomicrometry) demonstrated that L-NA and AG also abolished the improved recovery of myocardial function effected by late PC in group II. When rabbits were given L-NA or AG without prior PC (group IV [n=8] and group VI [n=6], respectively), infarct size did not differ from that observed in controls (53.8±4.3% and 59.8±4.3%, respectively), demonstrating that L-NA and AG do not increase the extent of cell death in nonpreconditioned myocardium. Conclusions —Taken together, these results indicate that in the conscious rabbit, the infarct-sparing effect of the late phase of ischemic PC is mediated by the activity of NOS and suggest that the specific isoform primarily responsible for this cardioprotective phenomenon is iNOS. Thus, NO appears to be a pivotal component of the pathophysiological cascade of late PC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Marber, M. S., Latchman, D. S., Walker, J. M., & Yellon, D. M. (1993) · Circulation · doi:10.1161/01.cir.88.3.1264 · Cited by 1,001
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., & Currie, M. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90357-n · Cited by 721
Nitric Oxide and Cardiac Function
Kelly, R. A., Balligand, J.-L., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 711
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., & Yazaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119709 · Cited by 687
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.
Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., & Michel, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.347 · Cited by 658
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Cited by
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
The Late Phase of Preconditioning
Bolli, R. (2000) · Circulation Research · doi:10.1161/01.res.87.11.972 · Cited by 757
Self-citationConsequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Bolli, R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1462 · Cited by 595
Self-citationStrategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
A novel protective effect of erythropoietin in the infarcted heart
Parsa, C. J., Matsumoto, A., Kim, J., Riel, R. U., Pascal, L. S., Walton, G. B., Thompson, R. B., Petrofski, J. A., Annex, B. H., Stamler, J. S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18200 · Cited by 548
Guo, Y., Jones, W. K., Xuan, Y.-T., Tang, X.-L., Bao, W., Wu, W.-J., Han, H., Laubach, V. E., Ping, P., Yang, Z., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11507 · Cited by 386
Self-citationShinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Self-citationThe myocardial JAK/STAT pathway: From protection to failure
BOENGLER, K., HILFIKERKLEINER, D., DREXLER, H., HEUSCH, G., & SCHULZ, R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.002 · Cited by 362
Jung, F., Palmer, L. A., Zhou, N., & Johns, R. A. (2000) · Circulation Research · doi:10.1161/01.res.86.3.319 · Cited by 317
Xuan, Y.-T., Tang, X.-L., Banerjee, S., Takano, H., Li, R. C. X., Han, H., Qiu, Y., Li, J.-J., & Bolli, R. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1095 · Cited by 300
Self-citationParacrine and autocrine effects of nitric oxide on myocardial function
Shah, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00072-8 · Cited by 293
An essential role of the JAK-STAT pathway in ischemic preconditioning
Xuan, Y.-T., Guo, Y., Han, H., Zhu, Y., & Bolli, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161283798 · Cited by 285
Self-citationCrucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury
Yang, Z., Zingarelli, B., & Szabó, C. (2000) · Circulation · doi:10.1161/01.cir.101.9.1019 · Cited by 282
Foresti, R., & Motterlini, R. (1999) · Free Radical Research · doi:10.1080/10715769900301031 · Cited by 274
Kapinya, K. J., Löwl, D., Fütterer, C., Maurer, M., Waschke, K. F., Isaev, N. K., & Dirnagl, U. (2002) · Stroke · doi:10.1161/01.str.0000020092.41820.58 · Cited by 272
The nitric oxide hypothesis of late preconditioning
Bolli, R., Dawn, B., Tang, X.-L., Qiu, Y., Ping, P., Xuan, Y.-T., Jones, W. K., Takano, H., Guo, Y., & Zhang, J. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050101 · Cited by 270
Self-citationBolli, R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00414-5 · Cited by 258
Self-citationPing, P., Takano, H., Zhang, J., Tang, X.-L., Qiu, Y., Li, R. C. X., Banerjee, S., Dawn, B., Balafonova, Z., & Bolli, R. (1999) · Circulation Research · doi:10.1161/01.res.84.5.587 · Cited by 257
Self-citation
Metadata
- Authors
- Takano, H., Manchikalapudi, S., Tang, X.-L., Qiu, Y., Rizvi, A., Jadoon, A. K., Zhang, Q., & Bolli, R.
- Venue
- Circulation
- Published
- 1998-08-04
- Volume
- 98
- Issue
- 5
- Pages
- 441-449
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1964972368
- Cited by
- 256
- References
- 66
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.